BDBM192475 US10526329, Compound 109::US11072611, Compound 109::US9670204, 109 ethyl2-(4-(2-ethyl-3-((4-(4-fluorophenyl)thiazol-2-yl)(methyl)amino)imidazo[1,2-a]pyridin-6-yl)piperidin-1-yl)acetate

SMILES CCOC(=O)CN1CCC(CC1)c1ccc2nc(CC)c(N(C)c3nc(cs3)-c3ccc(F)cc3)n2c1

InChI Key InChIKey=OJXQFNIBZPQTIN-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 192475   

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192475(US9670204, 109 ethyl2-(4-(2-ethyl-3-((4-(4-fluorop...)
Affinity DataIC50: 300nMpH: 8.5 T: 2°CAssay Description:Compound IC50 values are determined in a hENPP2 (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using LPC as substrate. 5 μL of a di...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/7/2018
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192475(US9670204, 109 ethyl2-(4-(2-ethyl-3-((4-(4-fluorop...)
Affinity DataIC50: 480nMAssay Description:Inhibition of glycosylated human ATX using LPC 16:0 as substrate after 30 mins by luminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2019
Entry Details Article
PubMed
TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192475(US9670204, 109 ethyl2-(4-(2-ethyl-3-((4-(4-fluorop...)
Affinity DataIC50: 300nMAssay Description:Compound IC50 values are determined in a hENPP2 (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using LPC as substrate.5 μL of a dil...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192475(US9670204, 109 ethyl2-(4-(2-ethyl-3-((4-(4-fluorop...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192475(US9670204, 109 ethyl2-(4-(2-ethyl-3-((4-(4-fluorop...)
Affinity DataIC50: 300nMAssay Description:TABLE V: 5 μL of a dilution series of compound, starting from 20 μM highest concentration, 1/5 dilution, is added to the wells. hENPP2 is u...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
Go to US Patent

TargetAutotaxin(Human)
Galapagos

US Patent
LigandPNGBDBM192475(US9670204, 109 ethyl2-(4-(2-ethyl-3-((4-(4-fluorop...)
Affinity DataIC50: 50nMAssay Description:TABLE VI: (UniProtKB/SwissProt Sequence ref Q13822) biochemical assay using the fluorogenic autotaxin substrate FS-3 as substrate. FS-3 is a doubly l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
Go to US Patent